fbpx

Anda Opioid Distribution and Health Insurance Costs Florida Class Action

This complaint against another company that deals in opioids takes a different tack than most. The complaint claims that Anda, Inc., a distributor, through its careless handling of the drugs, has caused health insurance costs to go up.

 “Since 1999,” the complaint says, “there have been more than 183,000 reported opioid-related deaths nationwide…” In addition, “some estimates state that the opioid crisis is costing governmental entities and private companies as much as $500 billion per year.

The federal Controlled Substances Act (CSA) requires distributors like Anda “to secure and monitor drugs as they travel through commerce, to protect them from theft, and to reject and report suspicious or unusual orders by downstream pharmacies, doctors, or patients.” 

The complaint details the measures the Drug Enforcement Administration (DEA) and industry groups have taken to warn of, and assist in the prevention of, diversion of drugs. These inclues the Automation of Reports and Consolidation Orders System (ARCOS) that monitors the flow of Schedule II drugs through commercial channels. 

The complaint claims Anda neglected its duties and thus “created conditions in which vast amounts of opioids flowed freely from Anda to abusers and drug dealers…” This created a diversion of drugs into the black market, exacerbating the opioid problem.

In fact, the complaint claims that Anda “has knowingly or negligently allowed diversion.” In May 2016, Anda agreed to a settlement with West Virginia about claims it had failed to maintain effective controls against diversion of controlled substances. It paid over $1.8 million as a fine.

Still, the complaint alleges, Anda has continued to allow the diversion of opioids. “Anda knew or should have known that the volume of opioids it allowed to flow into Florida was far in excess of what could be consumed for medically-necessary purposes…” Also, “Anda negligently or intentionally failed to adequately control its supply lines to prevent diversion.”

The result, the complaint alleges, is that “Anda’s conduct has created … the need for expensive medical treatment for a number of covered health conditions, resulting in increased insurance costs for Florida residents.” This includes “higher premiums, co-payments, and deductibles.”

The class for this action is all current Florida citizens, including individuals and entities, who bought and paid premiums for health insurance policies in Florida governed by Florida law, from 1996 through the present; and all current Florida citizens who paid for any portion of employer-provided health insurance in Florida governed by Florida law from 1996 through the present.

The complaint alleges violations of Florida’s Deceptive and Unfair Trade Practices Act, negligence, and civil conspiracy, among other things.

Article Type: Lawsuit
Topic: Consumer

Most Recent Case Event

Anda Opioid Distribution and Health Insurance Costs Florida Complaint

October 7, 2019

This complaint against another company that deals in opioids takes a different tack than most. The complaint claims that Anda, Inc., a distributor, through its careless handling of the drugs, has caused health insurance costs to go up.

anda_opioids_and_health_ins_costs_compl.pdf

Case Event History

Anda Opioid Distribution and Health Insurance Costs Florida Complaint

October 7, 2019

This complaint against another company that deals in opioids takes a different tack than most. The complaint claims that Anda, Inc., a distributor, through its careless handling of the drugs, has caused health insurance costs to go up.

anda_opioids_and_health_ins_costs_compl.pdf
Tags: Criminal Conspiracy, Negligence, Negligence Leading to Crime, Pharmaceuticals